Back to Agenda
SESSION 2: International Collaboration & Regulatory Systems Strengthening
Session Chair(s)
Alia Seoud Abdalla
Global Regulatory Sciences Head (Africa Cluster) , Pfizer, Egypt
Samvel Azatyan, MD
Deputy Secretary-General, Council For International Organizations of Medical Sciences (CIOMS), Switzerland
SESSION 2: International Collaboration & Regulatory Systems Strengthening
Speaker(s)
Strengthening Regulatory Systems, EDA’s Milestone towards WHO GBT Maturity Level 3
Dalia Abou Hussein
Quality Assurance (QA) General Director, Egyptian Drug Authority (EDA), Egypt
Saudi FDA’s ML4 & WLA Journey
Bandar Al Hammad, MPharm
Chief Pharmacist & Director of Veterinary Products Department, Saudi Food and Drug Authority (SFDA), Saudi Arabia
Tunisia’s experience with Reliance and role in North Africa Harmonisation initiative
Sonia Sebai Ben Amor
Head - National Control Laboratory National Regulatory Authority, Tunisian Medicines Agency (AEMPS), Tunisia
Convergence and Harmonisation in Africa: AMA operationalisation progress, AMA continental pilot, Africa Continental Reliance Framework and North Africa Harmonisation initiative
Nancy Yang Ngum
Public Health Officer (Public Health Expert), African Union Development Agency (AUDA-NEPAD), South Africa
Reliance Pilots - Industry experience with AMA continental pilot
Christine Ledimo
Senior Director: Regulatory Affcairs SSA, MSD , South Africa
Reliance Pilots - Industry experience with AMA continental pilot
Charlene Roopnarain
Regulatory Affairs Cluster Head - South Africa, Nigeria and East Africa, Merck Serono, South Africa
Panel Discussion with Q&A (With the additional participation of):
Enas Hijjih
Head of Bioequivalence Division- Registration department, Jordan Food and Drug Administration (JFDA), Jordan
Have an account?